 |
SYDNEY, Dec. 14, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the appointment of Karen Krumeich as Chief Financial Officer.
In this role, Ms Krumeich will focus on building and maintaining relationships with US investors, on preparing the company for...
Australian small business owners can now receive and compare business insurance quotes directly inside ChatGPT, in a move that signals a major shi...
With only 16% of retiring small businesses having a succession plan, tens of thousands risk closure as one in three owners nears retirement. Ne...
As workplaces settle into the new year and look for ways to strengthen culture, capability and connection, experts say corporate volunteering is e...
Global Hospitality Platform, Tabit, Reveals Five Ways to Maximise Benefits of Mobile-First Systems As Australian hospitality venues grapple with...
For over a decade, the most practical and effective advice we could offer an employee was to spot the typo. It was practical, it was free, and it wo...
New data from leading talent company Randstad Australia shows flexible working and work-life balance could be critical to addressing ongoing talen...